Pharma Market Access Insights - from Petauri Evidence

64 Avsnitt

1. Navigating US payer evidence needs to optimise market access

   Publicerades: 2024-11-27
2. Best practice RWE approaches to support economic modelling for HTA

   Publicerades: 2024-11-20
3. NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas

   Publicerades: 2024-11-18
4. De-mystifying the NHS – What you need to know about the NHS as a market for your health technology

   Publicerades: 2024-10-11
5. NHS primary care panel – the GP Contract and Operational Planning Guidance

   Publicerades: 2024-09-10
6. Engage NHS healthcare decision-makers with RWD

   Publicerades: 2024-08-12
7. Market access and reimbursement in Canada – changes at CADTH

   Publicerades: 2024-06-20
8. Rare Disease market access in the MENA and Nordic regions

   Publicerades: 2024-05-10
9. How does funding flow in NHSE Regions?

   Publicerades: 2024-04-09
10. NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)

    Publicerades: 2024-04-09
11. De-mystifying health economic model classifications and structures

    Publicerades: 2024-03-22
12. Evidence strategy for Medical Technologies and Diagnostics

    Publicerades: 2024-03-12
13. How to set your Pharma or Medtech product up for success in the US market

    Publicerades: 2024-02-26
14. What's happening with specialised commissioning in the NHS?

    Publicerades: 2024-02-12
15. Integrated care in NHS Wales – what can England learn from its neighbour?

    Publicerades: 2024-01-17
16. Market access in Italy: Reforms at AIFA

    Publicerades: 2023-12-18
17. Unmet need in NHS primary care – How can industry best support PCN leaders?

    Publicerades: 2023-11-28
18. Population health management: a community effort across health and life sciences

    Publicerades: 2023-11-01
19. Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access

    Publicerades: 2023-10-26
20. 6 areas of UK health policy for Medtech to pay attention to

    Publicerades: 2023-10-16